Due to the higher frequency of loss of PTEN than the oncogenic PIK3CA mutation in melanoma, the significance of the loss of the protein phosphatase activity of PTEN is conceivable in melanoma malignancy. This evidence concerns the gene PIK3CA and melanoma.